How big is the Human Liver Models Market?

The Human Liver Models Market size is expected to reach USD 0.3 billion in 2024 and grow at a CAGR of 10.98% to reach USD 0.46 billion by 2029. Read More

What is the current Human Liver Models Market size?

In 2024, the Human Liver Models Market size is expected to reach USD 0.3 billion. Read More

Who are the key players in Human Liver Models Market?

Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc. and Mimetas are the major companies operating in the Human Liver Models Market. Read More

Which is the fastest growing region in Human Liver Models Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Human Liver Models Market?

In 2024, the North America accounts for the largest market share in Human Liver Models Market. Read More

What years does this Human Liver Models Market cover, and what was the market size in 2023?

In 2023, the Human Liver Models Market size was estimated at USD 0.27 billion. The report covers the Human Liver Models Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Human Liver Models Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Human Liver Models Market Size & Share Analysis - Industry Research Report

Human Liver Models Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Human Liver Models Market is Segmented by Product Type (2D Models, 3D Models, Liver-On-A-Chip, and Others), Application (Education, Drug Discovery, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in USD for the Above Segments.

Human Liver Models Industry Overview

The global human liver models market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches, and regional expansions to increase their market share. The key market players operating in the market include Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc., and Mimetas, among others.